Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction

Drug and Alcohol Dependence

Volumn 110, Issue 3, 2010, Pages 200-207

  Olmstead, Todd A ^a   Ostrow, Cary D ^b   Carroll, Kathleen M ^c  

^a GEORGE MASON UNIVERSITY   (United States)

^b Liberation Programs   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CBT4CBT; Cognitive behavioral therapy; Cost effectiveness acceptability curves; Incremental cost effectiveness ratios

Indexed keywords

ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COMPUTER ASSISTED THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; HEALTH CARE ACCESS; HEALTH CARE COST; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; TREATMENT RESPONSE; ALCOHOL ABSTINENCE; BEHAVIOR, ADDICTIVE; ECONOMICS; FEMALE; MALE; SUBSTANCE-RELATED DISORDERS; TIME; TREATMENT OUTCOME;

BEHAVIOR, ADDICTIVE; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; SUBSTANCE-RELATED DISORDERS; TEMPERANCE; THERAPY, COMPUTER-ASSISTED; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954657073     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.02.022     Document Type: Article

References (30)

1. Anton R.F., O'Malley S.S., Ciraulo D.A., Cisler R.A., Couper D., Donovan D.M., Gastfriend D.R., Hosking J.D., Johnson B.A., LoCastro J.S., Longabaugh R., Mason B.J., Mattson M.E., Miller W.R., Pettinati H.M., Randall C.L., Swift R., Weiss R.D., Williams L.D., Zweben A. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006, 295:2003-2017. COMBINE Study Research Group.
2. Babor T.F., Higgins-Biddle J.C., Dauser D., Burleson J.A., Zarkin G.A., Bray J. Brief interventions for at-risk drinking: patient outcomes and cost-effectiveness in managed care organizations. Alcohol Alcohol 2006, 41:624-631.
3. Briggs A., O'Brien B. The death of cost-minimization analysis?. Health Econ. 2001, 10:179-184.
4. Carroll K.M. A Cognitive-Behavioral Approach: Treating Cocaine Addiction 1998, National Institute on Drug Abuse, Rockville, MD.
5. Carroll K.M., Ball S.A., Martino S., Nich C., Babuscio T.A., Nuro K., Gordon M.A., Portnoy G.A., Rounsaville B.J. Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am. J. Psychiatry 2008, 165:881-888.
6. Carroll K.M., Ball S., Martino S., Nich C., Babuscio T., Rounsaville B. Enduring effects of a computer-assisted training program for cognitive behavioral therapy: a 6-month follow-up of CBT4CBT. Drug Alcohol Depend. 2009, 100:178-181.
7. Carroll K.M., Easton C.J., Nich C., Hunkele K.A., Neavins T.M., Sinha R., Ford H.L., Vitolo S.A., Doebrick C.A., Rounsaville B.J. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J. Consult. Clin. Psychol. 2006, 74:955-966.
8. Carroll K.M., Fenton L.R., Ball S.A., Nich C., Frankforter T.L., Shi J., Rounsaville B.J. Efficacy of disulfiram and cognitive-behavioral therapy in cocaine-dependent outpatients: a randomized placebo controlled trial. Arch. Gen. Psychiatry 2004, 64:264-272.
9. Carroll K.M., Onken L.S. Behavioral therapies for drug abuse. Am. J. Psychiatry 2005, 62:1452-1460.
10. Carroll K.M., Rounsaville B.J., Nich C., Gordon L.T., Wirtz P.W., Gawin F.H. One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch. Gen. Psychiatry 1994, 51:989-999.
11. DeRubeis R.J., Crits-Christoph P. Empirically supported individual and group psychological treatments for adult mental disorders. J. Consult. Clin. Psychol. 1998, 66:37-52.
12. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B., Stoddart G.L. Methods for the Economic Evaluation of Health Care Programs 2005, Oxford University Press, Oxford, UK. 3rd ed.
13. Fenwick E., Claxton K., Schulpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001, 10:779-787.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV, Patient Edition 1995, American Psychiatric Press, Washington, DC.
15. Glick H.A., Doshi J.A., Sonnad S.S., Polsky D. Economic Evaluation in Clinical Trials 2007, Oxford University Press, Oxford, UK, pp. 198-202.
16. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-Effectiveness in Health and Medicine 1996, Oxford University Press, Oxford, UK.
17. Irvin J.E., Bowers C.A., Dunn M.E., Wong M.C. Efficacy of relapse prevention: a meta-analytic review. J. Consult. Clin. Psychol. 1999, 67:563-570.
18. Jones E.S., Moore B.A., Sindelar J.L., O'Connor P.G., Schottenfeld R.S., Fiellin D.A. Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients. Drug Alcohol Depend. 2009, 99:132-140.
19. McCrone P., Knapp M., Proudfoot J., Ryden C., Cavanagh K., Shapiro D., Ilson S., Gray J.A., Goldberg D., Mann A., Markis I., Everitt B., Tylee A. Cost-effectiveness of computerized cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br. J. Psychiatry 2004, 185:55-62.
20. McLellan A.T., Carise D., Kleber H.D. Can the national addiction treatment infrastructure support the public's demand for quality care?. J. Subst. Abuse Treat. 2003, 25:117-121.
21. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000, 284:1689-1695.
22. McLellan A.T., Meyers K. Contemporary addiction treatment: a review of systems problems for adults and adolescents. Biol. Psychiatry 2004, 56:764-770.
23. Morgenstern J., Morgan T.J., McCrady B.S., Keller D.S., Carroll K.M. Manual-guided cognitive-behavioral therapy training: a promising method for disseminating empirically supported substance abuse treatments to the practice community. Psychol. Addict. Behav. 2001, 15:83-88.
24. Olmstead T.A., Petry N. The cost effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients. Drug Alcohol Depend. 2009, 102:108-115.
25. Olmstead T.A., Sindelar J.L., Easton C.J., Carroll K.M. The cost-effectiveness of four treatments for marijuana dependence. Addiction 2007, 102:1443-1453.
26. Olmstead T.A., Sindelar J.L., Petry N. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend. 2007, 87:175-182.
27. Santa Ana E.J., Martino S., Ball S.A., Nich C., Frankforter T.L., Carroll K.M. What is usual about " treatment-as-usual" ? Data from two multisite effectiveness trials. J. Subst. Abuse Treat. 2008, 35:369-379.
28. Sholomskas D., Syracuse G., Ball S.A., Nuro K.F., Rounsaville B.J., Carroll K.M. We don't train in vain: a dissemination trial of three strategies for training clinicians in cognitive behavioral therapy. J. Consult. Clin. Psychol. 2005, 73:106-115.
29. Sindelar J.L., Olmstead T.A., Peirce J. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 2007, 102:1463-1471.
30. Weissman M.M., Verdeli H., Gameroff M.J., Bledsoe S.E., Betts K., Mufson L., Fitterling H., Wickramaratne P. National survey of psychotherapy training in psychiatry, psychology, and social work. Arch. Gen. Psychiatry 2006, 63:925-934.